All Stories

  1. Parainfluenza Fusion Peptide Promotes Membrane Fusion by Assembling into Oligomeric Porelike Structures
  2. The antimetastatic breast cancer activity of the viral protein‐derived peptide vCPP2319 as revealed by cellular biomechanics
  3. Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
  4. Exosomes and Brain Metastases: A Review on Their Role and Potential Applications
  5. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
  6. Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules
  7. Penetrating the Blood-Brain Barrier with New Peptide–Porphyrin Conjugates Having anti-HIV Activity
  8. Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
  9. Integrative Human Biochemistry
  10. Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein
  11. Effects of Diabetes on Microcirculation and Leukostasis in Retinal and Non-Ocular Tissues: Implications for Diabetic Retinopathy
  12. The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization
  13. The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization
  14. DPepH3, an Improved Peptide Shuttle for Receptor-independent Transport Across the Blood-Brain Barrier
  15. Antifungal and anti-biofilm activity of designed derivatives from kyotorphin
  16. Can citation metrics predict the true impact of scientific papers?
  17. Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
  18. Pharmaceutical Innovations: The Grand Challenges Ahead
  19. Enfuvirtide-Protoporphyrin IX Dual-Loaded Liposomes: In Vitro Evidence of Synergy against HIV-1 Entry into Cells
  20. Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models
  21. Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix–Loop–Helix Peptides with Cell Penetrating and Tumor Suppressor Properties
  22. Structural determinants conferring unusual long life in human serum to rattlesnake‐derived antimicrobial peptide Ctn[15‐34]
  23. Optical coherence tomography angiography study of the retinal vascular plexuses in type 1 diabetes without retinopathy
  24. Synthesis and Characterization of Peptide–Chitosan Conjugates (PepChis) with Lipid Bilayer Affinity and Antibacterial Activity
  25. A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography
  26. The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms
  27. Bacteriocins as Anticancer Peptides: A Biophysical Approach
  28. Fast NMR method to probe solvent accessibility and disordered regions in proteins
  29. Plant defensin PvD1 modulates the membrane composition of breast tumour-derived exosomes
  30. Designing of Artificial Peptides for an Improved Antiviral Activity
  31. Structure–Stability–Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles
  32. Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane
  33. Biologically active peptides linked to antibody fragments
  34. Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15–34), antimicrobial peptides from rattlesnake venom
  35. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood–Brain Barrier Model
  36. Neuropeptide Kyotorphin Impacts on Lipopolysaccharide-Induced Glucocorticoid-Mediated Inflammatory Response. A Molecular Link to Nociception, Neuroprotection, and Anti-Inflammatory Action
  37. New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins
  38. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance
  39. Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX
  40. Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood–Brain Barrier through a Receptor-Free Mechanism
  41. Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides
  42. Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives
  43. siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model
  44. Challenging metastatic breast cancer with the natural defensinPvD1
  45. Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates
  46. In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence
  47. Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles
  48. Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
  49. Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors
  50. Fusing simulation and experiment: The effect of mutations on the structure and activity of the influenza fusion peptide
  51. Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation
  52. Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity
  53. A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity
  54. Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model
  55. Anticancer Peptides: Prospective Innovation in Cancer Therapy
  56. Antibody Approaches To Treat Brain Diseases
  57. Improvement of the pharmacological properties of amidated kyotorphin by means of iodination
  58. Dps fromDeinococcus radiodurans: oligomeric forms of Dps1 with distinct cellular functions and Dps2 involved in metal storage
  59. The anti-inflammatory action of the analgesic kyotorphin neuropeptide derivatives: insights of a lipid-mediated mechanism
  60. Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets
  61. Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture
  62. Rethinking the capsid proteins of enveloped viruses: multifunctionality from genome packaging to genome transfection
  63. Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides
  64. Shifting gear in antimicrobial and anticancer peptides biophysical studies: from vesicles to cells
  65. Monitoring antibacterial permeabilization in real time using time-resolved flow cytometry
  66. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
  67. Integrative Human Biochemistry
  68. Introduction to Metabolism
  69. The Regulation of Metabolisms
  70. Regulation and Integration of Metabolism During Physical Activity
  71. The Families of Biological Molecules
  72. The Chemistry and Physics of Life
  73. Catabolism of the Major Biomolecules
  74. Introduction: Life Is Made of Molecules!
  75. Energy Conservation in Metabolism: The Mechanisms of ATP Synthesis
  76. Regulation and Integration of Metabolism During Hypoglycemia
  77. Metabolic Responses to Hyperglycemia: Regulation and Integration of Metabolism in the Absorptive State
  78. Correlation between membrane translocation and analgesic efficacy in kyotorphin derivatives
  79. Enhanced HIV Fusion Inhibitors Efficacy Requires Membrane Affinity and Exposure of the Pocket Binding Domain of C34 Derivatives
  80. Receptors and routes of dengue virus entry into the host cells
  81. The interaction of antibodies with lipid membranes unraveled by fluorescence methodologies
  82. Understanding Dengue Virus Capsid Protein Disordered N-Terminus and pep14-23-Based Inhibition
  83. The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer’s Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers
  84. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria
  85. Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors
  86. Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies
  87. The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
  88. Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure
  89. Dengue virus capsid protein interacts specifically with very low-density lipoproteins
  90. Dengue Virus Capsid Protein Delivers Nucleic Acids Intracellularly
  91. Dengue Virus Capsid Protein Interacts Specifically with Very Low-Density Lipoproteins
  92. New Broad-Spectrum Viral Fusion Inhibitors Act by Deleterious Effect on the Viral Membrane through the Production Singlet Oxygen Molecules
  93. Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein
  94. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action
  95. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures
  96. The Antimicrobial Activity of Sub3 is Dependent on Membrane Binding and Cell-Penetrating Ability
  97. N-Terminal AH2 segment of protein NS4B from hepatitis C virus. Binding to and interaction with model biomembranes
  98. Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach
  99. Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid
  100. A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
  101. Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
  102. Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs
  103. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria
  104. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems
  105. The Dengue Virus Capsid Protein Inhibitor Peptide Pep14-23 becomes Alpha-Helical upon Binding to Negative Lipids
  106. Dengue Virus Capsid Protein Binding to Lipid Droplets and its Inhibition. towards a New Drug Target
  107. From antimicrobial to anticancer peptides. A review
  108. Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer’s Disease Patients: Potential Diagnostic and Pharmacological Implications
  109. The application of biophysical techniques to study antimicrobial peptides
  110. Arginine-rich self-assembling peptides as potent antibacterial gels
  111. Antimicrobial Peptide rBPI21: A Translational Overview from Bench to Clinical Studies
  112. Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
  113. Anticancer Peptide SVS-1: Efficacy Precedes Membrane Neutralization
  114. Phosphatidylethanolamine Binding Is a Conserved Feature of Cyclotide-Membrane Interactions
  115. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif
  116. A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System
  117. Peptide Drug Discovery and Development: Translational Research in Academia and Industry. Edited by Miguel Castanho and Nuno C. Santos.
  118. Antimicrobial properties of analgesic kyotorphin peptides unraveled through atomic force microscopy
  119. Electron/proton coupling in biological energy transduction
  120. Short Stories - on Antimicrobial Peptides that are Too Short to Span the Membrane
  121. Biomedical applications of dipeptides and tripeptides
  122. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by brownian dynamics simulations on a coarse-grained model
  123. The Researching, Teaching, and Learning Triangle
  124. The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria
  125. Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Synergistically Potentiates Peptide-Membrane Interaction
  126. Relating Molecular-Level Events with Bacterial Killing by Antimicrobial Peptides
  127. Translocating the blood-brain barrier using electrostatics
  128. Biophysical characterization of polymyxin b interaction with LPS aggregates and membrane model systems
  129. The Application of Biophysical Techniques to Study Antimicrobial Peptides
  130. Decoding Distinct Membrane Interactions of HIV-1 Inhibitors Enfuvirtide and T-1249 using Atomic Force Microscopy Combined with Fluorescence Methodologies
  131. Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides
  132. Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is Potassium Ion Dependent and Is Mediated by LD Surface Proteins
  133. Peptide Drug Discovery and Development
  134. Chemical Conjugation of the Neuropeptide Kyotorphin and Ibuprofen Enhances Brain Targeting and Analgesia
  135. Inhibition of nociceptive responses after systemic administration of amidated kyotorphin
  136. Decoding the Membrane Activity of the Cyclotide Kalata B1
  137. Characterization of the Interaction of the Dengue Virus Capsid Protein with Lipid Droplets
  138. rBPI21 Causes (HEMI)Fusion and Leakage of Membranes and Promotes Massive Lipopolysaccharide Aggregation
  139. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes
  140. Using zeta-potential measurements to quantify peptide partition to lipid membranes
  141. Cationic liposomes are possible drug-delivery systems for HIV fusion inhibitor sifuvirtide
  142. The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide
  143. Quantitative assessment of peptide–lipid interactions.
  144. Drug–lipid interaction evaluation: why a 19th century solution?
  145. Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
  146. Escherichia coliCell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR
  147. Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes
  148. Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
  149. HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
  150. In Vitro Blood-Brain Barrier Models – Latest Advances and Therapeutic Applications in a Chronological Perspective
  151. Membrane-Active Peptides: Methods and Results on Structure and Function
  152. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: A kinetic study followed by surface plasmon resonance
  153. Unraveling the Molecular Basis of the Selectivity of the HIV-1 Fusion Inhibitor Sifuvirtide Towards Phosphatidylcholine-Rich Rigid Membranes
  154. rBPI21 Promotes Lipopolysaccharide Aggregation and Exerts Its Antimicrobial Effects by (Hemi)fusion of PG-Containing Membranes
  155. Interaction of the Dengue Virus Fusion Peptide with Membranes Assessed by NMR: The Essential Role of the Envelope Protein Trp101 for Membrane Fusion
  156. The Toxicity of Prion Protein Fragment PrP(106−126) is Not Mediated by Membrane Permeabilization as Shown by a M112W Substitution
  157. Interactions of HIV-1 Antibodies 2F5 and 4E10 with a gp41 Epitope Prebound to Host and Viral Membrane Model Systems
  158. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
  159. Synergistic Effects of the Membrane Actions of Cecropin-Melittin Antimicrobial Hybrid Peptide BP100
  160. Human Erythrocytes And Mononuclear Leukocytes Are Capable Of Concentrating HIV-1 Fusion Inhibitor Peptides In Their Membranes
  161. Fold-Unfold Transitions in the Selectivity and Mechanism of Action of the N-Terminal Fragment of the Bactericidal/Permeability-Increasing Protein (rBPI21)
  162. PrP(106-126) Does Not Interact with Membranes under Physiological Conditions
  163. Sifuvirtide Screens Rigid Membrane Surfaces. Establishment of a Correlation between Efficacy and Membrane Domain Selectivity among HIV Fusion Inhibitor Peptides
  164. Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2
  165. Translocation or membrane disintegration? Implication of peptide–membrane interactions in pep-1 activity
  166. Enfuvirtide effects on human erythrocytes and lymphocytes functional properties
  167. Biophysics meets membrane-active peptides
  168. Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering
  169. What can light scattering spectroscopy do for membrane-active peptide studies?
  170. Molecular interaction studies of peptides using steady-state fluorescence intensity. Static (de)quenching revisited
  171. The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers
  172. Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation
  173. Shiga toxin B-subunit sequential binding to its natural receptor in lipid membranes
  174. How to address CPP and AMP translocation? Methods to detect and quantify peptide internalizationin vitroandin vivo(Review)
  175. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1
  176. Cell-penetrating peptides and antimicrobial peptides: how different are they?
  177. The membranes’ role in the HIV-1 neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation
  178. Chiral Recognition ofD-Kyotorphin by Lipidic Membranes: Relevance Toward Improved Analgesic Efficiency
  179. Omiganan Pentahydrochloride in the Front Line of Clinical Applications of Antimicrobial Peptides
  180. Conformational and Orientational Guidance of the Analgesic Dipeptide Kyotorphin Induced by Lipidic Membranes:  Putative Correlation toward Receptor Docking
  181. An Insight on the Leading HIV Entry Inhibitors
  182. Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions
  183. Miguel A.R.B. Castanho
  184. Lipid membrane-induced optimization for ligand–receptor docking: recent tools and insights for the “membrane catalysis” model
  185. Translocation of β-Galactosidase Mediated by the Cell-Penetrating Peptide Pep-1 into Lipid Vesicles and Human HeLa Cells Is Driven by Membrane Electrostatic Potential†
  186. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides
  187. Overview of Common Spectroscopic Methods to Determine the Orientation/Alignment of Membrane Probes and Drugs in Lipidic Bilayers
  188. Environmental factors that enhance the action of the cell penetrating peptide pep-1
  189. Developing students' awareness of public understanding of science: A matter of survival?
  190. Lipidic Membranes Are Potential “Catalysts” in the Ligand Activity of the Multifunctional Pentapeptide Neokyotorphin
  191. Cholesterol modulates maculosin's orientation in model systems of biological membranes
  192. HIV Fusion Inhibitor Peptide T-1249 Is Able To Insert or Adsorb to Lipidic Bilayers. Putative Correlation with Improved Efficiency
  193. Consequences of Nonlytic Membrane Perturbation to the Translocation of the Cell Penetrating Peptide Pep-1 in Lipidic Vesicles†
  194. Does Aliphatic Chain Length Influence Carbocyanines' Orientation in Supported Lipid Multilayers?
  195. Filipin Orientation Revealed by Linear Dichroism. Implication for a Model of Action
  196. What do college life sciences students need to know about knowledge management?
  197. An overview of the biophysical applications of atomic force microscopy
  198. Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level
  199. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods
  200. Evaluation of Lipopolysaccharide Aggregation by Light Scattering Spectroscopy
  201. Lipossomas: a bala mágica acertou?
  202. Teaching Molecular Applications of the Particle-in-a-Ring Model Using Azulene
  203. Brownian dynamics simulation of the unsaturated lipidic molecules oleic and docosahexaenoic acid confined in a cellular membrane
  204. Joint determination by Brownian dynamics and fluorescence quenching of the in-depth location profile of biomolecules in membranes
  205. Revealing the Orientation of Nystatin and Amphotericin B in Lipidic Multilayers by UV−Vis Linear Dichroism
  206. Dealing with the challenges of teaching molecular biophysics to biochemistry majors through an heuristics-based approach
  207. Crude tall-oil sodium salts micellization in aqueous solutions studied by static and dynamic light scattering
  208. A photophysical study of the polyene antibiotic filipin
  209. Conference Report
  210. Meeting Report — Biochemical Education at the University Level, Lisbon, Portugal, October 30−31, 1999
  211. Conformation and dynamic properties of a saturated hydrocarbon chain confined in a model membrane: a Brownian dynamics simulation
  212. Overcoming Angular Dependency When Teaching Light Scattering Using a Spectrofluorometer: The Molecular Weight of Latex Beads
  213. The pentaene macrolide antibiotic filipin prefers more rigid DPPC bilayers: a fluorescence pressure dependence study
  214. Simulation of the distribution and diffusion of a rigid amphipathic particle embedded in a model membrane
  215. Reconstitution of Phospholipid Bilayer by an Atomic Force Microscope Tip
  216. Filipin-Induced Lesions in Planar Phospholipid Bilayers Imaged by Atomic Force Microscopy
  217. Fluorescence quenching data interpretation in biological systems
  218. Continuous particle size distribution analysis with dynamic light scattering
  219. Interaction of the Major Epitope Region of HIV Protein gp41 with Membrane Model Systems. A Fluorescence Spectroscopy Study†
  220. Separating the turbidity spectra of vesicles from the absorption spectra of membrane probes and other chromophores
  221. Structural characterization of organized systems of polysaccharides and phospholipids by light scattering spectroscopy and electron microscopy
  222. Structural characterization (shape and dimensions) and stability of polysaccharide/lipid nanoparticles
  223. Snatos, Nuno C., and Miguel A. R. B. Castanho. 1996. Biophys. J. 71:1641–1650
  224. The Shape, Dimension and Organisation of Maltodextrins Gel Fragments with and without Associated Phospholipids
  225. Teaching light scattering spectroscopy: the dimension and shape of tobacco mosaic virus
  226. The transverse location of the fluorescent probe trans-parinaric acid in lipid bilayers
  227. Filipin fluorescence quenching by spin-labeled probes: studies in aqueous solution and in a membrane model system
  228. Filipin and its interaction with cholesterol in aqueous media studied using static and dynamic light scattering
  229. Fluorescence study of a derivatized diacylglycerol incorporated in model membranes
  230. Rod-like cholesterol micelles in aqueous solution studied using polarized and depolarized dynamic light scattering
  231. Fluorescence study of the macrolide pentaene antibiotic filipin in aqueous solution and in a model system of membranes